よむ、つかう、まなぶ。

MC plus(エムシープラス)は、診療報酬・介護報酬改定関連のニュース、

資料、研修などをパッケージした総合メディアです。


03【資料1】新型コロナワクチンの接種について (78 ページ)

公開元URL https://www.mhlw.go.jp/stf/newpage_27303.html
出典情報 厚生科学審議会 予防接種・ワクチン分科会(第34回 8/8)《厚生労働省》
低解像度画像をダウンロード

資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。

参考資料一覧(5/5)
諸外国における新型コロナワクチン追加接種の状況について
国際連合
WHO. 2021. Coronavirus Disease (COVID-19). https://extranet.who.int/pqweb/vaccines/covid-19-vaccines [Accessed July 21, 2022].
WHO. 2022. Interim statement on the use of additional booster doses of Emergency Use Listed mRNA vaccines against COVID-19. https://www.who.int/news/item/17-05-2022-interim-statement-on-theuse-of-additional-booster-doses-of-emergency-use-listed-mrna-vaccines-against-covid-19 [Accessed Aug 5, 2022]
EU
European Vaccination Information Portal. 2021. COVID-19 vaccines. https://vaccination-info.eu/en/covid-19/covid-19-vaccines [Accessed July 21, 2022].
European Medicines Agency. 2021. Comirnaty and Spikevax: EMA recommendations on extra doses boosters - European Medicines Agency. https://www.ema.europa.eu/en/news/comirnaty-spikevaxema-recommendations-extra-doses-boosters [Accessed July 21, 2022].
European Medicines Agency. 2021. Spikevax: EMA recommendation on booster - European Medicines Agency. https://www.ema.europa.eu/en/news/spikevax-ema-recommendation-booster [Accessed
July 21, 2022].
European Medicines Agency. 2021. EMA and ECDC recommendations on heterologous vaccination courses against COVID-19 - European Medicines Agency. https://www.ema.europa.eu/en/news/emaecdc-recommendations-heterologous-vaccination-courses-against-covid-19 [Accessed July 21, 2022].
European Medicines Agency. 2022. EMA recommends authorisation of booster doses of Comirnaty from 12 years of age. https://www.ema.europa.eu/en/news/ema-recommends-authorisation-boosterdoses-comirnaty-12-years-age [Accessed July 21, 2022].
EMA. 2022. COVID-19: Joint statement from ECDC and EMA on the administration of a fourth dose of mRNA vaccines. [online] Available at:
<https://www.ema.europa.eu/en/news/ema-recommends-authorisation-nuvaxovid-adolescents-aged-12-17> [Accessed 21 July 2022].
EMA. 2022. ECDC and EMA update recommendations on additional booster doses of mRNA COVID-19 vaccines - European Medicines Agency. [online] Available at:
<https://www.ema.europa.eu/en/news/ecdc-ema-update-recommendations-additional-booster-doses-mrna-covid-19-vaccines> [Accessed 21 July 2022].

78